Takeda: all 1,753 studies
Page 14 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.
- A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia AActive, not recruitingNCT04158934
- A Study of People With Multiple Myeloma (MM) in Portugal (CharisMMa-Portugal)CompletedNCT04135963
- A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or IICompletedNCT04130191
- TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion MutationsCompletedNCT04129502Phase 3
- Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After TreatmentTerminatedNCT04102163
- A Study of VPRIV in Participants With Gaucher Disease Previously Treated With Other Enzyme Replacement Therapies or Substrate Reduction TherapiesTerminatedNCT04094181
- Study of TAK-925 in Participants With Obstructive Sleep Apnea (OSA) Who Are Experiencing Excessive Daytime Sleepiness (EDS) Despite Adequate Use of Continuous Positive Airway Pressure (CPAP)CompletedNCT04091425Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-988 in Healthy ParticipantsWithdrawnNCT04082481Phase 1
- Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]CompletedNCT04002180
- A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)CompletedNCT03984097Phase 1
- A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian FederationCompletedNCT03942263
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy ParticipantsCompletedNCT03933488Phase 1
- Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy)WithdrawnNCT03888534Phase 1
- A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic HypoparathyroidismWithdrawnNCT03878953Phase 3
- A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North AmericaCompletedNCT03845400
- Post Marketing Surveillance Study for ADYNOVATE in South KoreaCompletedNCT03824522
- Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)CompletedNCT03716700
- A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)CompletedNCT03668249
- A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell TransplantationWithdrawnNCT03608501Phase 2
- Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)CompletedNCT03582449
- Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"CompletedNCT03555578
- A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) InhibitorsCompletedNCT03546894
- Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP]CompletedNCT03519672
- A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real LifeTerminatedNCT03378388
- Efficacy and Safety of TAK-653 in Treatment-Resistant DepressionWithdrawnNCT03312894Phase 2
- Hunter Outcome Survey (HOS)CompletedNCT03292887
- Fabry Outcome Survey (FOS)CompletedNCT03289065
- Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative ColitisActive, not recruitingNCT03221036Phase 3
- Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life PracticeCompletedNCT03199794
- Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe HemophiliaCompletedNCT03185897
- A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)TerminatedNCT03173092Phase 4
- Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging MarketsCompletedNCT03090139
- Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator InterviewsCompletedNCT03054389
- Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes MellitusWithdrawnNCT03042325Phase 4
- Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel DiseaseWithdrawnNCT03035058Phase 3
- THIN Database Study: Resource Use and Outcomes in Patients With Adrenal Insufficiency Prescribed Hydrocortisone: Immediate, or Modified Release, or PrednisoloneCompletedNCT03013166
- A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD)CompletedNCT02986724
- An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential HypertensionWithdrawnNCT02969265Phase 3
- A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)CompletedNCT02932618Phase 3
- Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP)TerminatedNCT02926092
- Post-Marketing Surveillance (Usage Results Study) of RIXUBIS in Adult and Pediatric Patients With Haemophilia B in South KoreaCompletedNCT02922231
- Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's DiseaseWithdrawnNCT02913508Phase 2
- A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell LymphomasCompletedNCT02788916
- An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung CancerNo longer availableNCT02784158
- TAK-438_110 Drug Interaction With Cytochrome P450 3A4 (CYP3A4) Inhibitor ClarithromycinCompletedNCT02774902Phase 1
- Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction StudyWithdrawnNCT02760615Phase 4
- A Study of TAK-788 in Adults With Non-Small Cell Lung CancerActive, not recruitingNCT02716116Phase 1/2
- A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult ParticipantsWithdrawnNCT02713061Phase 2
- OTIS Vedolizumab Pregnancy Exposure RegistryCompletedNCT02678052
- GAS-Hem Feasibility StudyCompletedNCT02674997
- Entyvio (Vedolizumab) Long Term Safety StudyCompletedNCT02674308
- Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia ACompletedNCT02634723
- Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung CancerTerminatedNCT02629848Phase 3
- Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric SurgeryWithdrawnNCT02616315Phase 4
- A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years OldCompletedNCT02616302Phase 2
- A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years OldTerminatedNCT02615184Phase 2
- Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia ACompletedNCT02610127
- Efficacy and Safety of SM101 in the Treatment of IgA NephropathyWithdrawnNCT02605525Phase 2
- Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)CompletedNCT02593188
- A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in MyelofibrosisWithdrawnNCT02584777Phase 2
- Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy StudyCompletedNCT02584569Phase 1
- Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHDCompletedNCT02578030Phase 1
- Phase 1 Bioavailability Study of SYR-322METCompletedNCT02508168Phase 1
- Epidemiological Study in Thai Participants With HypertensionCompletedNCT02467855
- An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG®TerminatedNCT02455024
- Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 MonthsWithdrawnNCT02442752Phase 1
- Phase 1 Single Subcutaneous Dose Study of MLN1202WithdrawnNCT02426021Phase 1
- Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With MacroalbuminuriaWithdrawnNCT02410499Phase 2
- A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.WithdrawnNCT02400775Phase 4
- An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal CancerActive, not recruitingNCT02394834
- Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular DiseaseWithdrawnNCT02388971Phase 2
- Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human VolunteersCompletedNCT02328612Phase 1
- A Phase 1, Single and Multiple Dose Study of TAK-137WithdrawnNCT02322606Phase 1
- Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)CompletedNCT02216084Phase 1
- Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBISCompletedNCT02190149
- Short Term Observational Study in DEB PatientsCompletedNCT02178969
- China ADVATE PTP StudyCompletedNCT02170402Phase 4
- TAK-438 - Safety, Blood Levels & Effects of Repeated DosesCompletedNCT02141711Phase 1
- Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Western Male Subjects, Preliminary Food Effect Analysis, and an Ethnic Comparison With Japanese SubjectsCompletedNCT02141698Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-438 in Healthy Male ParticipantsCompletedNCT02123953Phase 1
- Safety, Tolerability and Pharmacokinetics of TAK-438 in Healthy Male ParticipantsCompletedNCT02123927Phase 1
- A Phase I Clinical Pharmacology Study of TAK-233 in Healthy SubjectsCompletedNCT02113020Phase 1
- Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project)TerminatedNCT02095015
- ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)CompletedNCT02093741
- ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)CompletedNCT02078427
- Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.CompletedNCT02072330Phase 2/3
- Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation of Deferitazole (Magnesium Hydroxide Salt)WithdrawnNCT02065401Phase 1
- A Phase I Study of MLN6907 in Patients With Metastatic ColorectalCompletedNCT02056015Phase 1
- Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder SyndromeCompletedNCT02024945
- Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on HemodialysisWithdrawnNCT02015780Phase 3
- Registry for Participants With Short Bowel SyndromeActive, not recruitingNCT01990040
- Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodiesNo longer availableNCT01968655
- Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican AdultsCompletedNCT01967264Phase 1
- Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile DysfunctionWithdrawnNCT01967251Phase 2
- Natural History Study of Children With Metachromatic LeukodystrophyTerminatedNCT01963650
- Treatment of Iron Overload Requiring Chelation TherapyWithdrawnNCT01927913Phase 2
- A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy SubjectsCompletedNCT01923207Phase 1
- A Registry for Participants With Chronic HypoparathyroidismCompletedNCT01922440
- Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable SchizophreniaTerminatedNCT01900522Phase 1
- An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic LeukodystrophyCompletedNCT01887938Phase 1/2